Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Antiretroviral agents during pregnancy: consequences on hematologic parameters in HIV-exposed, uninfected newborn infant.

El Beitune P, Duarte G.

Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):59-63.

PMID:
16876310
2.

Effect of antiretroviral drugs on maternal CD4 lymphocyte counts, HIV-1 RNA levels, and anthropometric parameters of their neonates.

El Beitune P, Duarte G, Machado AA, Quintana SM, Figueiró-Filho EA, Abduch R.

Clinics (Sao Paulo). 2005 Jun;60(3):207-12.

3.

Effects of antiretroviral agents during pregnancy on liver enzymes and amylase in HIV-exposed, uninfected newborn infants.

El Beitune P, Duarte G, Campbell O, Quintana SM, Rodrigues LC.

Braz J Infect Dis. 2007 Jun;11(3):314-7.

4.

Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.

Feiterna-Sperling C, Weizsaecker K, Bührer C, Casteleyn S, Loui A, Schmitz T, Wahn V, Obladen M.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):43-51.

PMID:
17356471
5.

Effect of maternal use of antiretroviral agents on serum insulin levels of the newborn infant.

El Beitune P, Duarte G, Foss MC, Montenegro RM Jr, Quintana SM, Figueiró-Filho EA, Nogueira AA.

Diabetes Care. 2005 Apr;28(4):856-9.

PMID:
15793185
6.

Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.

Poirier MC, Divi RL, Al-Harthi L, Olivero OA, Nguyen V, Walker B, Landay AL, Walker VE, Charurat M, Blattner WA; Women and Infants Transmission Study (WITS) Group..

J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):175-83.

PMID:
12794551
7.

Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir.

Divi RL, Walker VE, Wade NA, Nagashima K, Seilkop SK, Adams ME, Nesel CJ, O'Neill JP, Abrams EJ, Poirier MC.

AIDS. 2004 Apr 30;18(7):1013-21.

PMID:
15096804
8.

Antiretroviral agents and acid-base balance at delivery of the neonate.

El-Beitune P, Duarte G, de Morais EN, Campbell O, Spara-Gadelha P, Mauad-Filho F, Quintana SM, Rodrigues LC.

Braz J Med Biol Res. 2007 Jul;40(7):957-61.

9.

Effect of antiretroviral agents on carbohydrate metabolism in HIV-1 infected pregnant women.

El Beitune P, Duarte G, Foss MC, Montenegro RM Jr, Spara P, Quintana SM, Figueiró-Filho EA, da Costa AG, Filho FM.

Diabetes Metab Res Rev. 2006 Jan-Feb;22(1):59-63.

PMID:
16021650
10.

Altered heterochromatin organization after perinatal exposure to zidovudine.

Senda S, Blanche S, Costagliola D, Cibert C, Nigon F, Firtion G, Floch C, Parat S, Viegas-Péquignot E.

Antivir Ther. 2007;12(2):179-87. Erratum in: Antivir Ther. 2007;12(3):429.

PMID:
17503660
11.

Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants.

Taha TE, Kumwenda N, Gibbons A, Hoover D, Lema V, Fiscus S, Mukiibi J, Liomba G, Broadhead R.

AIDS. 2002 Apr 12;16(6):851-8.

PMID:
11919486
12.

Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study.

Pacheco SE, McIntosh K, Lu M, Mofenson LM, Diaz C, Foca M, Frederick M, Handelsman E, Hayani K, Shearer WT; Women and Infants Transmission Study..

J Infect Dis. 2006 Oct 15;194(8):1089-97.

13.

Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy.

Melvin AJ, Kang M, Hitti J, Livingston E, Cohn SE, Stocker V, Ross AC, Watts H, McComsey GA.

Antivir Ther. 2008;13(3):349-55.

PMID:
18572747
14.

Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants.

Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S; Enquête Périnatale Française Study Group..

AIDS. 2003 Sep 26;17(14):2053-61.

PMID:
14502008
15.

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.

Brogly SB, Ylitalo N, Mofenson LM, Oleske J, Van Dyke R, Crain MJ, Abzug MJ, Brady M, Jean-Philippe P, Hughes MD, Seage GR 3rd.

AIDS. 2007 May 11;21(8):929-38.

PMID:
17457086
16.

Maternal antiretrovirals and hepatic enzyme, hematologic abnormalities among human immunodeficiency virus type 1-uninfected infants: the NISDI perinatal study.

Mussi-Pinhata MM, Rego MA, Freimanis L, Kakehasi FM, Machado DM, Cardoso EM, Read JS; NISDI Perinatal Protocol Study Group..

Pediatr Infect Dis J. 2007 Nov;26(11):1032-7.

PMID:
17984811
17.

Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

Suksomboon N, Poolsup N, Ket-Aim S.

J Clin Pharm Ther. 2007 Jun;32(3):293-311. Review.

PMID:
17489882
18.

Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy.

Tseng A, Conly J, Fletcher D, Keystone D, Salit I, Walmsley S.

Clin Infect Dis. 1998 Oct;27(4):908-9. No abstract available.

19.

Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.

Ekouevi DK, Touré R, Becquet R, Viho I, Sakarovitch C, Rouet F, Towne-Gold B, Fassinou P, Leroy V, Blanche S, Dabis F; Agence Nationale de Recherches Sur le SIDA 1201/1202 Ditrame Plus Study Group..

Pediatrics. 2006 Oct;118(4):e1071-7.

20.

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.

Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Swai A, Lipyoga R, Mhalu F, Biberfeld G; Mitra Plus Study Team..

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):406-16. doi: 10.1097/QAI.0b013e3181b323ff.

PMID:
19730269
Items per page

Supplemental Content

Support Center